Hsu, Jessica C. https://orcid.org/0000-0002-3599-2834
Tang, Zhongmin https://orcid.org/0000-0002-1532-8004
Eremina, Olga E. https://orcid.org/0000-0002-2776-4743
Sofias, Alexandros Marios https://orcid.org/0000-0002-7475-2526
Lammers, Twan https://orcid.org/0000-0002-1090-6805
Lovell, Jonathan F. https://orcid.org/0000-0002-9052-884X
Zavaleta, Cristina
Cai, Weibo https://orcid.org/0000-0003-4641-0833
Cormode, David P. https://orcid.org/0000-0002-8391-9500
Article History
Accepted: 20 February 2023
First Online: 13 April 2023
Competing interests
: W.C. is a scientific advisor, stockholder and grantee of Focus-X Therapeutics, Inc.; a consultant and grantee of Actithera, Inc.; and a scientific advisor of Portrai, Inc. D.P.C. is named as an inventor on patents pertaining to nanoparticle contrast agents and holds stock in Daimroc Imaging. All other authors declare no competing interests.